Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03674528 · ClinicalTrials.gov registry record
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 152
- Enrollment target
NCT03674528 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 152 participants.
The verdict
NCT03674528 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 152 participants
- Enrollment target
Study Summary
The overall goal of this collaborative research program is to develop, validate and translate advanced quantitative magnetic resonance (MR) biomarkers of obesity-associated non-alcoholic fatty liver disease (NAFLD). This protocol represents the research plan for two distinct phases. The first phase is an optimization phase. The second phase is designed to complete a rigorous test of conventional and advanced MRE techniques. Complementary anthropometric, laboratory, and MR measures will also be collected to characterize the cohort and identify factors that affect MRE performance
Interventions
- DIAGNOSTIC_TEST Liver biopsy
- OTHER Magnetic Resonance Elastography (MRE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-05-04 |
| Est. Completion | 2024-06-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03674528
The ClinicalTrials.gov registry entry for NCT03674528 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liver biopsy is the first listed.
NCT03674528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03674528 about?
NCT03674528 is a clinical study titled "Technical Validation of MR Biomarkers of Obesity-Associated NAFLD". The overall goal of this collaborative research program is to develop, validate and translate advanced quantitative magnetic resonance (MR) biomarkers of obesity-associated non-alcoholic fatty liver disease (NAFLD). This protocol represents the research plan for two distinct phases. The first phase ...
What is the current status of trial NCT03674528?
This trial is currently completed. The enrollment target is 152 participants. The study started on 2018-05-04. Estimated completion is 2024-06-11.
What interventions are being tested in trial NCT03674528?
The interventions under investigation include: Liver biopsy (DIAGNOSTIC_TEST), Magnetic Resonance Elastography (MRE) (OTHER).
Who is sponsoring clinical trial NCT03674528?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.